Clinical Trials Logo

Alcohol Abuse clinical trials

View clinical trials related to Alcohol Abuse.

Filter by:

NCT ID: NCT06419647 Not yet recruiting - Clinical trials for Alcohol Use Disorder

Tracking Mood: The Effects of Daily Mood Tracking VAS on Alcohol Consumption in Adult Heavy Drinkers

Start date: May 2024
Phase: N/A
Study type: Interventional

The study aims to investigate the effects that mood tracking may have on the alcohol consumption of adults who consume more than 20 UK units of alcohol per week, classifying as high-risk drinkers. The intervention group will track their mood on a daily basis with a visual analogue scale, while the control group will report their daily time spent online. The hypothesis, based on a series of prior pilot studies on alcohol tracking methods, is that mood tracking can reduce alcohol consumption in high-risk drinkers and therefore be a suitable addition to interventions related to decreasing alcohol consumption in heavy drinkers. The study will be conducted online through the Prolific platform.

NCT ID: NCT06416059 Recruiting - Anxiety Clinical Trials

A Mobile Intervention for Black Individuals Who Engage in Hazardous Drinking

Start date: May 15, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to develop and examine a culturally adapted, mobile health application for the Android and iOS platform. The application uses a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Black hazardous drinkers with clinical anxiety.

NCT ID: NCT06415721 Not yet recruiting - Clinical trials for Alcohol Use Disorder

Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

Alcohol Use Disorders are currently positioned as the third leading cause of preventable death in the United States, constituting a humanitarian crisis with substantial financial burden on society and medical facilities. While several pharmacological interventions exist, 60% of individuals who seek these treatments relapse to alcohol within 6 months. These high relapse rates are due in part to elevated brain response to alcohol cues in the environment. This study seeks to evaluate the efficacy of one session of functional Magnetic Resonance Imaging (fMRI) guided transcranial magnetic stimulation (TMS) as a strategy to reduce brain reactivity to alcohol cues.

NCT ID: NCT06405607 Not yet recruiting - Clinical trials for Alcohol Use Disorder

Psilocybin vs Ketamine for Alcohol Use Disorder

Psi vs Ket
Start date: June 2024
Phase: Phase 2
Study type: Interventional

This study will collect data that measures the effects of a psychedelic intervention on patients struggling with alcohol use disorder (AUD). The study design will be a double blind, randomized, active-comparator trial with two study arms. Subjects randomized to Arm 1 (n=40) will receive individual psychotherapy sessions plus a 30 mg dose of oral psilocybin. Arm 2 subjects (n=40) will receive individual psychotherapy sessions and a 0.75 mg/kg dose of intramuscular ketamine.

NCT ID: NCT06367348 Not yet recruiting - HIV/AIDS Clinical Trials

An Economic and Relationship-strengthening Intervention to Reduce Alcohol Use in Malawi

Start date: January 2025
Phase: N/A
Study type: Interventional

With a full-scale randomized control trial, the investigators will evaluate the efficacy and cost effectiveness of Mlambe, an economic and relationship-strengthening intervention that provides incentivized saving accounts, financial literacy training, and relationship skills education to break the cycle of poverty around drinking, strengthen couple support and communication, and reduce heavy drinking among HIV-affected married couples with a partner who drinks alcohol in Malawi.

NCT ID: NCT06265506 Recruiting - Clinical trials for Alcohol Use Disorder

Virtual Incentive Treatment for Alcohol

VITA
Start date: June 18, 2024
Phase: N/A
Study type: Interventional

The overall objective of this program of research is to utilize phosphatidylethanol (PEth), a blood-based biomarker that can detect alcohol use for up to 28 days to deliver a feasible telehealth-based 26-week CM intervention. This study will test a telehealth PEth-based CM model in a sample of adults with AUD (n=200), recruited via online platforms by randomizing individuals to six months of 1) an online cognitive behavioral therapy for AUD (CBT4CBT) and telehealth PEth-based CM (CM condition) or 2) CBT4CBT and reinforcers for submitting blood samples (no abstinence required) (control condition). Investigators will assess group differences in PEth-defined abstinence and regular excessive drinking (PEth >= 200 ng/mL), and alcohol-related harms (e.g., smoking, drug use). This study will address important gaps in CM research by assessing outcomes during a 12-month follow-up, which is much longer than most previous CM studies; using a conceptual model to identify predictors of post-treatment abstinence. Investigators will conduct an economic analysis to place the cost of this model in the context of downstream CM-associated cost-offsets and improvements in personal and public health.

NCT ID: NCT06247306 Not yet recruiting - Alcohol Abuse Clinical Trials

Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption

NeuStress
Start date: March 1, 2024
Phase: N/A
Study type: Interventional

In this research project, the aim is to discover the role specific brain networks play in the relationship between stress reactions and the desire for alcohol and alcohol consumption. To investigate this question, various brain imaging methods as well as cognitive tasks are combined. Various questionnaires are sampled and brain scans are conducted. Individuals interested in participating in the study have to fulfill certain criteria... - no serious medical or mental health diagnosis - problematic alcohol drinking habits - interested in improving drinking habits ...and undergo various non-invasive procedures - filling out several questionnaires concerning personality and habits - undergoing a mental performance task while being in a brain scanner (MRI) - attempting to regulate their own brain activity while lying in the MRI scanner - filling out an electronic diary for 6 weeks - concerning daily mood, stress, and alcohol habits Participants will be randomly allocated to either one of 2 experimental groups. Both groups undergo the same tasks, receive the same instructions and only differ regarding some aspects of the brain self-regulation task .

NCT ID: NCT06190236 Recruiting - Clinical trials for Alcohol Use Disorder

Integration of Neurofunctional Phenotyping Into Investigation of CBT4CBT for AUD

Start date: April 10, 2024
Phase: N/A
Study type: Interventional

Alcohol use and misuse are prevalent in the United States. Alcohol use disorder (AUD) is the most common substance use disorder. Evidence-based treatments are effective; however, most people with AUD do not receive treatment, and among those who do, responses to treatment modalities vary. Technology provides the opportunity to expand treatment and improve outcomes. Therefore, the overall goal of this project is to incorporate neurofunctional phenotyping into a preliminary investigation of the feasibility of providing mobile CBT4CBT for AUD among a non-treatment seeking population

NCT ID: NCT05970484 Recruiting - Clinical trials for Alcohol Use Disorder

Supporting Women in the UK Armed Forces Who Consume Alcohol at an Increased Risk: Refining the DrinksRation Platform

RationW
Start date: September 1, 2023
Phase: N/A
Study type: Interventional

Alcohol misuse is common in the Armed Forces (AF), with prevalence higher than in the general population. To date, initiatives to support alcohol misuse have focused on males, who represent ~90% of the AF. However, female veterans drink disproportionally more than female members of the public. In this study, the investigators will refine and evaluate DrinksRation - the only automated brief digital intervention supporting the United Kingdom (UK) Armed Forces to manage and reduce the amount they drink - to tailor the intervention to the specific needs of female veterans. The changes will then be assessed using a confirmatory Randomized Controlled Trial (RCT), which includes a minimum of 148 (74 in each arm) female veterans (to be recruited).

NCT ID: NCT05948605 Recruiting - Clinical trials for Alcohol Use Disorder

EMPOWER AUD Pivotal Trial

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

Multi-site, double-blinded, prospective, randomized, sham-controlled study